KATSUYUKI TAKAHASHI

Kindai University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (7)

Ryohei Fujii

Kansai Medical University

JAPAN

View details

Hiroaki Ikesue

Kobe University Hospital

JAPAN

View details

Yutaka Negoro

University of Fukui

JAPAN

View details

Kaito Yamashiro

Kindai University Hospital

JAPAN

View details

Shota SUZUKI

Assistant Professor

Nara Medical University Hospital

JAPAN

View details

Hitoshi Kawazoe

Associate Professor

Keio University Faculty of Pharmacy

JAPAN

View details

Ryo Inose

Kyoto Pharmaceutical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

KATSUYUKI TAKAHASHI

Research Interests

Explore related searches

Contact this professor

Articles (13)

A multicenter retrospective study evaluating the effect of proton pump inhibitors on adjuvant tegafur-uracil/leucovorin efficacy for stage II–III colorectal cancer

Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin Plus Etoposide Therapy

The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study

Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study.

Safety profile of the concomitant use of atorvastatin and cyclosporine in renal transplant recipients

Long‐term use of foscarnet is associated with an increased incidence of acute kidney injury in hematopoietic stem cell transplant patients: A retrospective observational study

Association between the Co-administration of Histamine H<sub>2</sub> Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis.

Proton pump inhibitors affect capecitabine efficacy in patients with stage II-III colorectal cancer: a multicenter retrospective study.

Suppression of the doxorubicin response by hypoxia-inducible factor-1α is strictly dependent on oxygen concentrations under hypoxic conditions

Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer

Prognostic Nutrition Index as an Indicator of Therapeutic Response to Lenvatinib Therapy in Hepatocellular Carcinoma

Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia

Safety profile of the concomitant use of foscarnet and aerosolized pentamidine in allogeneic hematopoietic stem cell transplantation recipients

Collaborators (7)

Ryohei Fujii

Hiroaki Ikesue

Yutaka Negoro

Kaito Yamashiro

Shota SUZUKI

Hitoshi Kawazoe

Ryo Inose

Make your next move.